Patents by Inventor Ming Tat Ling

Ming Tat Ling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
    Patent number: 9439941
    Abstract: The present invention provides methods, compositions, and kits wherein nanomaterials are used for inhibiting cancer stem cell division, colony formation, spheroid formation and self-renewal. The present invention also provides methods, compositions, and kits wherein nanomaterials are used for treating cancer, coating tumors, and inhibiting metastasis. The present invention also provides methods, compositions, and kits wherein nanomaterials are used for inducing cells to go into stasis. The present invention further provides methods for isolating tumors, inhibiting bleeding, and marking margins of tumors and organs during surgery with a nanomaterial.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: September 13, 2016
    Assignee: The University of Hong Kong
    Inventors: Rutledge Ellis-Behnke, Patrick Ming Tat Ling
  • USE OF TOCOTRIENOL COMPOSITION FOR THE PREVENTION OF CANCER
    Publication number: 20110195910
    Abstract: The present invention is directed to a method of preventing cancer or preventing the recurrence of cancer after undergoing a cancer treatment by administering a composition comprising at least one of ?-tocotrienol or ?-tocotrienol, wherein the cancer is selected from the group consisting of melanoma, prostate cancer, prostate intraepithelial neoplasia, colon cancer, liver cancer, bladder cancer, breast cancer and lung cancer. The present invention is further directed to a composition comprising at least one of ?-tocotrienol or ?-tocotrienol and Docetaxel and/or Dacarbazine, and to a method of inhibiting or arresting or reversing of cancer by administering a composition comprising at least one of ?-tocotrienol or ?-tocotrienol together with Docetaxel and/or Dacarbazine. The present invention is also directed to methods of manufacturing those compositions.
    Type: Application
    Filed: October 20, 2009
    Publication date: August 11, 2011
    Applicant: DAVOS LIFE SCIENCE PTE. LTD.
    Inventors: Ming Tat Ling, Wei Ney Yap, Yong Chuan Wong, Yee Leng Daniel Yap
  • Nano Cancer Barrier Device (NCBD) to Immobilize and Inhibit the Division of Metastic Cancer Stem Cells
    Publication number: 20110144023
    Abstract: The present invention provides methods, compositions, and kits wherein nanomaterials are used for inhibiting cancer stem cell division, colony formation, spheroid formation and self-renewal. The present invention also provides methods, compositions, and kits wherein nanomaterials are used for treating cancer, coating tumors, and inhibiting metastasis. The present invention also provides methods, compositions, and kits wherein nanomaterials are used for inducing cells to go into stasis. The present invention further provides methods for isolating tumors, inhibiting bleeding, and marking margins of tumors and organs during surgery with a nanomaterial.
    Type: Application
    Filed: December 14, 2010
    Publication date: June 16, 2011
    Applicant: The University of Hong Kong
    Inventors: Rutledge Ellis-Behnke, Patrick Ming Tat Ling